Cerebral Protection Systems for Preventing Stroke during Transcatheter Aortic Valve Implantation

Note: The following ratings and comments reflect the opinions and consensus of an expert panel convened by ECRI Institute to review information on this topic.

Anticipated Utilization: 5(Expected to be used by 80% to 100% of eligible patients)

Although transcatheter aortic valve implantation (TAVI)-related stroke is rare, the clinical and economic impacts can be devastating for patients and other stakeholders. Thus, technology that offers even a modest reduction in procedure-related stroke would likely be used in most TAVI procedures. Positive health outcomes data, potential liability issues, and pressure from third-party payers might encourage providers to incorporate cerebral protection into TAVI protocols. The U.S. Transcatheter Valve Therapy Registry reported that almost 55,000 patients underwent TAVI from January 2012 to December 2015.

**Estimated Adoption Status:...